Search Results
Results found for "FRET BRET"
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
Here, we present two cryo-electron microscopy structures of CX3CR1-Gi1 complexes in ligand-free and CX3CL1
- Unlocking the Future of Medicine: Advancements in GPCR Research
Feel free to reach out to us at Hello@DrGPCR.com. Events, Meetings, and Webinars NEW November 5 - 7, 2024 | 16th Annual PEGS Europe September 18, 2024 | FREE
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
GPCR Binders, Drugs, and more Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid-Free Get your 5-day free trial TODAY!
- 📰 GPCR Weekly News, September 18 to 24, 2023
cancer Methods & Updates in GPCR Research Target immobilization on glass microfiber membranes as a label-free Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
Here, we present comparative MSM analyses of 150-μs simulations of opsin in cholesterol-free and cholesterol-rich
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Get your 5-day free trial TODAY!
- Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5...
We showed a diversity of ligand-free forms of CCR5 at the cell surface constituted of various oligomeric
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
No worries – you can sign up for a 5-day FREE trial! Get your 5-day free trial TODAY!
- Dr. Simone Promel
Register here (free): https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #podcast
- 📰 GPCR Weekly News, August 28 to September 3, 2023
Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron in GPCRs as Drug Targets: Allosteric Function and Biased Signaling" at the DOT NEW October 3, 2023 | FREE
- 📰 GPCR Weekly News, May 8 to 14, 2023
FREE Symposium - IPI Surfacing (June 15, 2023) Training School on “Cell-based assays to study Adhesion (June 28 - 30, 2023) FREE 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
agonist determined by serial femtosecond crystallography (SFX) at the Pohang Accelerator Laboratory X-Ray Free
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Scientists in Developing Nations If you reside and work in a developing country, complete this form for free Get your 5-day free trial TODAY!
- Structures of β 1-adrenergic receptor in complex with Gs and ligands of different efficacies
Biochemical investigations uncover that the intermediate state complex comprising β1-AR and nucleotide-free
- GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation
inflammation via enhancing NLRP3 inflammasome activation in macrophages "The putative medium-chain free
- Identification and functional characterization of the sulfakinin and sulfakinin receptor in the...
in mortality of D. armandi and also led to an increase in trehalose and a decrease in glycogen and free
- From GPCR Data Chaos to Decisive Action
. 🚀 Book your free 30-minute strategy call Let’s unlock the momentum your GPCR program needs. 👉 https
- 📰 GPCR Weekly News, March 13 to 19, 2023
GPCR Binders, Drugs, and more Design of Drug Efficacy Guided by Free Energy Simulations of the β2-Adrenoceptor Monitoring the Reversibility of GPCR Signaling by Combining Photochromic Ligands with Label-free Impedance
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
attempted to close the gap by generating highly refined model structures of C5aR2, respectively in free
- New Resources in GPCRdb
Reserve your spot for free at: https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #GPCR #GPCRs #DrGPCR
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCR Events, Meetings, and Webinars FREE Symposium - IPI Surfacing (June 15, 2023) GPCRs in drug discovery (June 28 - 30, 2023) FREE 11th Adrenoceptor Symposium: Adrenoceptors and GPCR Signalling (June 30 - July
- Beyond HEK293 — Terry Hébert on iPSC-Derived GPCR Models, Live April 16,
Send your questions ahead of time to Terry@DrGPCR.org Free for Kenakin Brief subscribers.
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
. 🚀 Book your free 30-minute precision audit — before your next DMTA cycle costs another $200K Let’
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Premium delivers curated, noise-free intelligence every week : expert lectures, classified industry updates
- 📰 GPCR Weekly News
Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells. Oligomerization of the heteromeric γ-aminobutyric acid receptor GABAB in a eukaryotic cell-free system
- Conjugation Strategies for Probe Development
coupling  is the most suited for bioconjugation with proteins, DNA, etc, thanks to its reaction with the free
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
fluorescent label upon receptor binding, thus does not require the physical separation of the bound and free due to the ratiometric nature of the assay, the FA signal depends on the concentration of both the free Therefore, FA requires sufficient receptor concentration to achieve free achieve depletion of free fluorescent
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
a median follow-up interval of 67.1 months, a significant trend towards reduced distant metastasis-free
- Molecular creativity in drug discovery
GPCR Premium Membership Gives You an Edge Premium delivers curated, noise-free intelligence every week
- Radioligands vs. Fluorescent Ligands: Binding Assays
If you are curious about fluorescent probes, fluorescent probe design or GPCR tools, feel free to contact
















